ADCT
ADC Therapeutics SA
1.30$
-1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +74.1% | -45.3% | -0.6% | -4.3% | -1.1% | +1.0% | +47.6% | -89.7% | -7.4% | +0.9% | +821.9% | – | |
| – | +6.6% | -92.9% | +1,158.2% | +41.1% | -42.4% | +49.8% | -25.2% | +10.4% | +206.4% | -60.1% | +86.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -199.1% | – | – | +17.4% | -394.4% | – | -97.4% | -3,127.7% | – | – | – | |
| – | -50.7% | +63.1% | -94.4% | +620.0% | -58.3% | +193.3% | -95.7% | -80.6% | +429.7% | +176.3% | -99.6% | – | |
| – | -22.8% | +4.0% | -94.4% | +620.0% | -58.3% | +193.3% | -95.7% | -80.6% | – | -104.7% | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +197.7% | -65.7% | +27,623.9% | -100.9% | +27.4% | – | +34,506.3% | -100.2% | – | -101.0% | -83.0% | – | |
| – | – | – | – | -139.3% | – | – | – | -142.7% | – | -214.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.